STAB1 and posterior cortical atrophy: These target genes (MBNL2, TNS1 and STAB1) were also identified to have prognostic significance regarding biochemical recurrence (BCR)-free and disease-free survival of patients with PCa based on the data from The Cancer Genome Atlas (TCGA) [25].